Effect of Multitarget tDCS for Neuropathic Pain

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Neuropathic Pain
Interventions
DEVICE

Mutitarget tDCS

Subjects will receive 20 minutes of active transcranial direct current stimulation at 2mA applied to DLPFC and M1 alternately for ten consecutive weekdays, with each target stimulated for 5 sessions.

DEVICE

Single-target tDCS

Subjects will receive 20 minutes of active transcranial direct current stimulation at 2mA applied to M1 for ten consecutive weekdays.

DEVICE

Sham tDCS

Subjects will receive 20 minutes of sham transcranial direct current stimulation. Ramps up and down will be applied for 15 seconds each at the beginning and end of the session. The current will be 0 mA during the interval between the initial and final ramps. Subjects will undergo stimulation once a day for ten consecutive weekdays.

All Listed Sponsors
collaborator

Beijing Tiantan Hospital

OTHER

collaborator

Second Affiliated Hospital of Tsinghua University

OTHER

lead

Xuanwu Hospital, Beijing

OTHER

NCT06510725 - Effect of Multitarget tDCS for Neuropathic Pain | Biotech Hunter | Biotech Hunter